IgA-nefropátia: vizsgálatok itt: Oroszország

3 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Where

  Rostov-on-Don, Saint Petersburg

  Életkor

  18 év to 100 év

  People

  540 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04557462 · EU 2023-508690-92-00
• No phaseTaking people
  Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

  Where

  Saint Petersburg

  Életkor

  18 év to 75 év

  People

  240

  Run by

  St. Petersburg State Pavlov Medical University

  See details and how to joinNCT07074951
• No phaseTaking people
  Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

  Where

  Moscow

  Életkor

  18 év and over

  People

  30

  Run by

  Botkin Hospital

  See details and how to joinNCT07056595